A novel viral mechanism for dysregulation of β-catenin in Kaposi's sarcoma-associated herpesvirus latency

Nature Medicine

Volumn 9, Issue 3, 2003, Pages 300-306

  Fujimuro, Masahiro ^a   Wu, Frederick Y ^a   Aprhys, Colette ^a   Kajumbula, Henry ^a   Young, David B ^a   Hayward, Gary S ^a   Hayward, S Diane ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AXIN; BETA CATENIN; CELL NUCLEUS ANTIGEN; GSK 3BETA KINASE; LATENCY ASSOCIATED NUCLEAR ANTIGEN; PROTEIN SERINE THREONINE KINASE; RNA; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE; CELL CYCLE S PHASE; CELL PROLIFERATION; HELA CELL; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; LYMPHOMA CELL; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UPREGULATION; VIRUS LATENCY;

AMINO ACID SEQUENCE; ANTIGENS, VIRAL; BETA CATENIN; BINDING SITES; CELL CYCLE; CYCLIN D1; CYCLOHEXIMIDE; CYTOSKELETAL PROTEINS; GENES, REPORTER; GLYCOGEN SYNTHASE KINASE 3; HERPESVIRUS 8, HUMAN; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEIN SYNTHESIS INHIBITORS; RNA, SMALL INTERFERING; SEQUENCE ALIGNMENT; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED; VIRUS LATENCY;

DNA VIRUSES; HERPESVIRIDAE; HERPESVIRUS 8; HUMAN HERPESVIRUS 8; LANA;

EID: 0037348372     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm829     Document Type: Article

References (38)

1. Chang, Y. et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266, 1865-1869 (1994).
2. Moore, P.S. & Chang, Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N. Engl. J. Med. 332, 1181-1185 (1995).
3. Cesarman, E., Chang, Y., Moore, P.S., Said, J.W. & Knowles, D.M. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl J. Med. 332, 1186-1191 (1995).
4. Soulier, J. et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86, 1276-1280 (1995).
5. Kedes, D.H., Lagunoff, M., Renne, R. & Ganem, D. Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus. Clin. Invest. 100, 2606-2610 (1997).
6. Rainbow, L. et al. The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J. Virol 71, 5915-5921 (1997).
7. Dupin, N. et al. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc. Natl. Acad. Sci. USA. 96, 4546-4551 (1999).
8. Parravicini, C. et al. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Am. J. Pathol. 156, 743-749 (2000).
9. Olsen, S.J., Sarid, R., Chang, Y. & Moore, P.S. Evaluation of the latency-associated nuclear antigen (ORF73) of Kaposi's sarcoma-associated herpesvirus by peptide mapping and bacterially expressed recombinant western blot assay. J. Infect. Dis. 182, 306-310 (2000).
10. Ballestas, M.E., Chatis, P.A. & Kaye, K.M. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284, 641-644 (1999).
11. Cotter, M.A. & Robertson, E.S. The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. Virology 264, 254-264 (1999).
12. Hu, J., Garber, A.C. & Renne, R. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells. J. Virol. 76, 11677-11687 (2002).
13. Krithivas, A., Young, D.B., Liao, G., Greene, D. & Hayward, S.D. Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells. J. Virol. 74, 9637-9645 (2000).
14. Radkov, S.A., Kellam, P. & Boshoff, C. The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat. Med. 6, 1121-1127 (2000).
15. Friborg, J.J., Kong, W., Hottiger, M.O. & Nabel, G.J. p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402, 889-894 (1999).
16. Polakis, P. Wnt signaling and cancer. Genes Dev. 14, 1837-1851 (2000).
17. Kitagawa, M. et al. An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of β-catenin. EMBO J. 18, 2401-2410 (1999).
18. Ben-Ze'ev, A., Shtutman, M. & Zhurinsky, J. The integration of cell adhesion with gene expression: The role of β-catenin. Exp. Cell Res. 261, 75-82 (2000).
19. Barker, N., Morin, P.J. & Clevers, H. The yin-yang of TCF/β-catenin signaling. Adv. Cancer Res. 77, 1 -24 (2000).
20. He, T.C. et al. Identification of c-MYC as a target of the APC pathway. Science 281, 1509-1512 (1998).
21. Tetsu, O. & McCormick, F. β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398, 422-426 (1999).
22. −/− colon carcinoma. Science 275, 1784-1787 (1997).
23. Morin, P.J. et al. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275, 1787-1790 (1997).
24. Sarid, R., Flore, O., Bohenzky, R.A., Chang, Y. & Moore, P.S. Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1). J. Virol. 72, 1005-1012 (1998).
25. Fakhari, F.D. & Dittmer, D.P. Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCR. J. Virol. 76, 6213-6223 (2002).
26. Jenner, R.G., Alba, M.M., Boshoff, C. & Kellam, P. Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays. J. Viral. 75, 891-902 (2001).
27. Rivas, C., Thlick, A.E., Parravicini, C., Moore, P.S. & Chang, Y. Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53. J. Virol. 75, 429-438 (2001).
28. Brummelkamp, T.R., Bernards, R. & Agami, R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550-553 (2002).
29. Diehl, J.A., Cheng, M., Roussel, M.F. & Sherr, C.J. Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12, 3499-3511 (1998).
30. Webster, M.T. et al. Sequence variants of the axin gene in breast, colon, and other cancers: an analysis of mutations that interfere with GSK3 binding. Gene Chromosomes Cancer 28, 443-453 (2000).
31. Reya, T. et al. Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism. Immunity 13, 15-24 (2000).
32. van de Wetering, M., Oosterwegel, M., van Norren, K. & Clevers, H. Sox-4, an Sry-like HMG box protein, is a transcriptional activator in lymphocytes. EMBO J. 12, 3847-3854 (1993).
33. Hovanes, K. et al. β-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nat. Genet. 28, 53-57 (2001).
34. Wright, M., Aikawa, M., Szeto, W. & Papkoff, J. identification of a Wnt-responsive signal transduction pathway in primary endothelial cells. Biochem. Biophys. Res. Commun. 263, 384-388 (1999).
35. Morin, P.J. β-catenin signaling and cancer. Bioessays 21, 1021-1030 (1999).
36. Schreiber, E., Matthias, P., Muller, M.M. & Schaffner, W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17, 6419 (1989).
37. Wu, F.Y. et al. Origin-independent assembly of Kaposi's sarcoma-associated herpesvirus DNA replication compartments in transient cotransfection assays and association with the ORF-K8 protein and cellular PML. J. Virol. 75, 1487-1506 (2001).
38. Ciufo, D.M. et al. Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures. J. Virol. 75, 5614-5626 (2001).